Article
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer.
Breast cancer research : BCR - 4 Mar 2015
Soady Kelly J, Kendrick Howard, Gao Qiong, Tutt Andrew, Zvelebil Marketa, Ordonez Liliana D, Quist Jelmar, Tan David Wei-Min, Isacke Clare M, Grigoriadis Anita, Smalley Matthew J
Abstract excerpt
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumours in which chemotherapy, the current mainstay of systemic treatment, is often initially beneficial but with a high risk of relapse and metastasis. There is currently no means of predicting which TNBC will relapse. We tested the hypothesis that the biological properties of normal stem cells are re-activated in tumour metastasis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
